Suppr超能文献

通过静脉注射经辐照的肿瘤细胞使小鼠对肿瘤抗原无反应时,小鼠体内存在CD4 + T抑制细胞。

Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells.

作者信息

Rakhmilevich A L, North R J, Dye E S

机构信息

Trudeau Institute, Inc., Saranac Lake, NY 12983.

出版信息

Int J Cancer. 1993 Sep 9;55(2):338-43. doi: 10.1002/ijc.2910550226.

Abstract

We used in vivo and in vitro assays to determine whether suppressor cells are generated in mice rendered unresponsive to tumor-specific antigens by intravenous (i.v.) injection of non-replicating tumor cells. The results show that a single i.v. injection of 2 x 10(7) irradiated P815 tumor cells resulted in the induction of a state of specific unresponsiveness to tumor-associated antigens, as revealed by the inability of the treated mice to achieve immunologically-mediated regression of an intradermal P815 tumor containing C. parvum, or to generate effector T cells capable of causing rejection of a P815 tumor in T-cell-deficient (T x B) test recipients. Failure to respond to tumor antigens was associated with the presence in spleen of CD4+ T cells capable, on passive transfer, of suppressing adoptive T-cell-mediated tumor regression in T x B recipients. However, the same CD4+ suppressor cells failed to inhibit the generation of tumor-specific cytotoxic T lymphocytes (CTL) in vitro. On the contrary, spleen cells from mice made unresponsive by i.v. injection of tumor cells were primed to generate CTL in response to tumor antigens in vitro. Taken together, our results suggest that unresponsiveness induced by i.v. injection of tumor antigens is an active process mediated, at least in part, by CD4+ T suppressor cells, and that these cells coexist in the spleen with antigen-primed effector T cells with a capacity to generate tumor-specific CTL when released from suppression in vitro.

摘要

我们采用体内和体外试验,以确定通过静脉注射(i.v.)非复制性肿瘤细胞使小鼠对肿瘤特异性抗原无反应时,是否会产生抑制细胞。结果显示,单次静脉注射2×10⁷个经照射的P815肿瘤细胞可诱导对肿瘤相关抗原产生特异性无反应状态,这表现为经处理的小鼠无法实现对含有微小隐孢子虫的皮内P815肿瘤的免疫介导消退,也无法产生能够在T细胞缺陷(T×B)试验受体中引起P815肿瘤排斥的效应T细胞。对肿瘤抗原无反应与脾脏中存在CD4⁺T细胞有关,这些细胞在被动转移时能够抑制T×B受体中过继性T细胞介导的肿瘤消退。然而,相同的CD4⁺抑制细胞在体外未能抑制肿瘤特异性细胞毒性T淋巴细胞(CTL)的产生。相反,通过静脉注射肿瘤细胞而变得无反应的小鼠的脾细胞在体外被激发以响应肿瘤抗原产生CTL。综上所述,我们的结果表明,静脉注射肿瘤抗原诱导的无反应是一个至少部分由CD4⁺T抑制细胞介导的主动过程,并且这些细胞在脾脏中与抗原激发的效应T细胞共存,当在体外从抑制状态释放时具有产生肿瘤特异性CTL的能力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验